ALTERATIONS IN FIBRINOLYSIS AND COAGULATION ASSOCIATED WITH CARDIOPULMONARY BYPASS

被引:37
作者
PORTER, JM
SILVER, D
机构
关键词
D O I
10.1016/S0022-5223(19)42782-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:869 / &
相关论文
共 30 条
[21]  
RATNOFF OD, 1951, J LAB CLIN MED, V37, P316
[22]   THROMBOCYTOPENIA AND BLEEDING TENDENCY AFTER EXTRACORPOREAL CIRCULATION [J].
SCHMIDT, PJ ;
BARANOVSKY, A ;
PEDEN, JC ;
BRECHER, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1961, 265 (24) :1181-+
[23]  
Stefanini M, 1955, HEMORRHAGIC DISORDER
[24]   BEHAVIOUR OF THE ANTITHROMBIN TIME AFTER EXTRACORPOREAL CIRCULATION OF BLOOD [J].
THIES, HA .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1960, 4 (3-4) :400-409
[25]  
TOCANTINS LM, 1964, BLOOD COAGULATION HE
[26]  
VONKAULLA KN, 1958, J THORAC SURG, V36, P519
[27]   UROKINASE EXCRETION IN MAN - A METHOD OF DETERMINATION AND CONSIDERATION OF ITS SIGNIFICANCE [J].
VONKAULLA, KN ;
RIGGENBACH, N .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1960, 5 (02) :162-178
[28]   INTRAVENOUS PROTEIN-FREE PYROGEN - A POWERFUL FIBRINOLYTIC AGENT IN MAN [J].
VONKAULLA, KN .
CIRCULATION, 1958, 17 (02) :187-198
[29]  
WOODS JE, 1967, MAYO CLIN PROC, V42, P318
[30]  
WRIGHT T A, 1959, Can J Surg, V2, P142